Related Experiment Videos
Mortality prediction models for pediatric intensive care: comparison of overall and subgroup specific performance
Idse H E Visser1, Jan A Hazelzet, Marcel J I J Albers
1Department of Pediatrics, Erasmus MC, Sophia Children's Hospital, Rotterdam, The Netherlands. i.visser@erasmusmc.nl
Insights
The Paediatric Index of Mortality 2 (PIM2) and Pediatric Risk of Mortality 3 (PRISM3-24) models effectively predict mortality in pediatric intensive care units (PICUs), including neonates, but struggle with prolonged stays.
Area of Science:
- Pediatric critical care medicine
- Clinical epidemiology
- Healthcare outcomes research
Background:
- Accurate mortality prediction is crucial for resource allocation and clinical decision-making in pediatric intensive care units (PICUs).
- Existing models like the Pediatric Index of Mortality (PIM) and Pediatric Risk of Mortality (PRISM) require validation in diverse patient populations and settings.
Purpose of the Study:
- To validate the performance of PIM and PRISM model variants for mortality prediction in a Dutch PICU population.
- To assess model performance across various subgroups, including neonates, different diagnoses, admission urgency, and length of stay (LoS).
Main Methods:
- Comparative analysis of PIM and PRISM model variants using calibration and discrimination metrics (Area Under the Curve - AUC).
- Evaluation of model performance in the overall cohort and predefined subgroups (diagnoses, age, urgency, LoS).
- Data from 12,040 admissions of patients <16 years in 8 Dutch PICUs (2006-2009) were analyzed, excluding referred or rapidly deceased patients.
Main Results:
- PIM2 variants demonstrated the best calibration. All models showed good discrimination (AUC > 0.83), including in neonates.
- PRISM3-24 exhibited the highest discrimination overall (AUC 0.90) and in most subgroups (13/14).
- Model performance, particularly discrimination (AUC < 0.73), declined for patients with LoS > 6 days.
Conclusions:
- PIM2 and PRISM3-24 (after recalibration) are suitable for individualized mortality risk prediction in Western European PICUs.
- Both models demonstrate good discrimination in most subgroups, including neonates.
- Predictive accuracy is limited for patients with extended PICU stays (>6 days).
Aim:
To validate paediatric index of mortality (PIM) and pediatric risk of mortality (PRISM) models within the overall population as well as in specific subgroups in pediatric intensive care units (PICUs).
Methods:
Variants of PIM and PRISM prediction models were compared with respect to calibration (agreement between predicted risks and observed mortality) and discrimination (area under the receiver operating characteristic curve, AUC). We considered performance in the overall study population and in subgroups, defined by diagnoses, age and urgency at admission, and length of stay (LoS) at the PICU. We analyzed data from consecutive patients younger than 16 years admitted to the eight PICUs in the Netherlands between February 2006 and October 2009. Patients referred to another ICU or deceased within 2 h after admission were excluded.
Results:
A total of 12,040 admissions were included, with 412 deaths. Variants of PIM2 were best calibrated. All models discriminated well, also in patients <28 days of age (neonates), with overall higher AUC for PRISM variants (PIM = 0.83, PIM2 = 0.85, PIM2-ANZ06 = 0.86, PIM2-ANZ08 = 0.85, PRISM = 0.88, PRISM3-24 = 0.90). Best discrimination for PRISM3-24 was confirmed in 13 out of 14 subgroup categories. After recalibration PRISM3-24 predicted accurately in most (12 out of 14) categories. Discrimination was poorer for all models (AUC < 0.73) after LoS of >6 days at the PICU.
Conclusion:
All models discriminated well, also in most subgroups including neonates, but had difficulties predicting mortality for patients >6 days at the PICU. In a western European setting both the PIM2(-ANZ06) or a recalibrated version of PRISM3-24 are suited for overall individualized risk prediction.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Cancer Survival Analysis
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Kaplan-Meier Approach
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...